Curadigm products

Curadigm’s technology was developed to address a critical challenge facing intravenously administered therapeutics: How can you efficiently deliver a drug to your tissue of interest without rapid clearance? To address this, we developed technology that reduces unwanted hepatic clearance, resulting in a temporary increase in blood bioavailability so the therapeutic they can reach its target sites. This leads to an enhanced treatment effect, all without modifying the therapeutic in any way.